Literature DB >> 17003471

Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.

Atsuko Kamijo-Ikemori1, Takeshi Sugaya, Ayako Obama, Junya Hiroi, Hiroshi Miura, Minoru Watanabe, Toshio Kumai, Ritsuko Ohtani-Kaneko, Kazuaki Hirata, Kenjiro Kimura.   

Abstract

Liver-type fatty-acid-binding protein (L-FABP), which has high affinity for long-chain fatty acid oxidation products, may be an effective endogenous antioxidant. To examine the role of L-FABP in tubulointerstitial damage, we used a unilateral ureteral obstruction (UUO) model. We established human L-FABP (hL-FABP) gene transgenic (Tg) mice and compared the tubulointerstitial pathology of the Tg mice (n = 23) with that of the wild-type (WT) mice (n = 23). Mice were sacrificed on days 2, 4, 5, or 7 after UUO. Although mouse L-FABP was not expressed in WT mice, hL-FABP was expressed in the proximal tubules of the Tg mice with UUO (UUO-Tg) and in sham-operated Tg mice. The expression of renal hL-FABP was significantly increased in UUO-Tg compared with sham-operated Tg mice. The number of macrophages (F4/80) infiltrating the interstitium and the level of expression of MCP-1 and MCP-3 were significantly lower in UUO-Tg kidneys compared with UUO-WT kidneys. In UUO-Tg kidneys, the degree of the tubulointerstitial injury and the deposition of type I collagen were significantly lower than that of UUO-WT kidneys. On day 7, lipid peroxidation product accumulated in the UUO-WT kidneys but not in that of UUO-Tg kidneys. In conclusion, renal L-FABP may reduce the oxidative stress in the UUO model, ameliorating tubulointerstitial damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17003471      PMCID: PMC1780178          DOI: 10.2353/ajpath.2006.060131

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

1.  Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice.

Authors:  Minoru Satoh; Naoki Kashihara; Yasushi Yamasaki; Keisuke Maruyama; Kazunori Okamoto; Youhei Maeshima; Hitoshi Sugiyama; Takeshi Sugaya; Kazuo Murakami; Hirofumi Makino
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

2.  Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target.

Authors:  G Martin; H Poirier; N Hennuyer; D Crombie; J C Fruchart; R A Heyman; P Besnard; J Auwerx
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

3.  Antioxidative function of L-FABP in L-FABP stably transfected Chang liver cells.

Authors:  Guqi Wang; Yuewen Gong; Judy Anderson; Dongfeng Sun; Gerald Minuk; Michael S Roberts; Frank J Burczynski
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

4.  Gene expression of CC chemokines in experimental acute tubulointerstitial nephritis.

Authors:  Z L Ou; Y Natori; Y Natori
Journal:  J Lab Clin Med       Date:  1999-01

5.  Phytanic acid is ligand and transcriptional activator of murine liver fatty acid binding protein.

Authors:  C Wolfrum; P Ellinghaus; M Fobker; U Seedorf; G Assmann; T Börchers; F Spener
Journal:  J Lipid Res       Date:  1999-04       Impact factor: 5.922

6.  Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction.

Authors:  N Kawada; T Moriyama; A Ando; M Fukunaga; T Miyata; K Kurokawa; E Imai; M Hori
Journal:  Kidney Int       Date:  1999-09       Impact factor: 10.612

7.  Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: a multicenter trial.

Authors:  Atsuko Kamijo; Takeshi Sugaya; Akihisa Hikawa; Masaya Yamanouchi; Yasunobu Hirata; Toshihiko Ishimitsu; Atsushi Numabe; Masao Takagi; Hiroshi Hayakawa; Fumiko Tabei; Tokuichiro Sugimoto; Naofumi Mise; Kenjiro Kimura
Journal:  J Lab Clin Med       Date:  2005-03

8.  Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants.

Authors:  Betty Pat; Tao Yang; Chuize Kong; Dianne Watters; David W Johnson; Glenda Gobe
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

9.  Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide.

Authors:  J B de Haan; C Bladier; P Griffiths; M Kelner; R D O'Shea; N S Cheung; R T Bronson; M J Silvestro; S Wild; S S Zheng; P M Beart; P J Hertzog; I Kola
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

Review 10.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

View more
  34 in total

Review 1.  The use of targeted biomarkers for chronic kidney disease.

Authors:  Prasad Devarajan
Journal:  Adv Chronic Kidney Dis       Date:  2010-11       Impact factor: 3.620

2.  Preliminary study of urinary excretion of liver-type fatty acid-binding protein in a cat model of chronic kidney disease.

Authors:  Akiko Watanabe; Keiichi Ohata; Tsuyoshi Oikawa; Takeshi Sugaya; Masao Miyazaki; Hiroshi Satoh; Masaaki Katayama
Journal:  Can J Vet Res       Date:  2021-04       Impact factor: 1.310

Review 3.  Marking renal injury: can we move beyond serum creatinine?

Authors:  Jessica L Slocum; Michael Heung; Subramaniam Pennathur
Journal:  Transl Res       Date:  2012-02-03       Impact factor: 7.012

Review 4.  Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application.

Authors:  Zubaida Al-Ismaili; Ana Palijan; Michael Zappitelli
Journal:  Pediatr Nephrol       Date:  2010-07-10       Impact factor: 3.714

5.  Urinary biomarkers of cell cycle arrest are delayed predictors of acute kidney injury after pediatric cardiopulmonary bypass.

Authors:  Liqun Dong; Qing Ma; Michael Bennett; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2017-07-28       Impact factor: 3.714

6.  Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

Authors:  Amélie Dendooven; Olivia van Oostrom; Dionne M van der Giezen; Jan Willem Leeuwis; Cristel Snijckers; Jaap A Joles; Elizabeth J Robertson; Marianne C Verhaar; Tri Q Nguyen; Roel Goldschmeding
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

7.  Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Authors:  Katsuomi Matsui; Atsuko Kamijo-Ikemorif; Takeshi Sugaya; Takashi Yasuda; Kenjiro Kimura
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

8.  Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury.

Authors:  Michael A Ferguson; Vishal S Vaidya; Sushrut S Waikar; Fitz B Collings; Kelsey E Sunderland; Costas J Gioules; Joseph V Bonventre
Journal:  Kidney Int       Date:  2009-11-25       Impact factor: 10.612

9.  Comparison of the effects of L: -carnitine and alpha-tocopherol on acute ureteral obstruction-induced renal oxidative imbalance and altered energy metabolism in rats.

Authors:  S Mostafa Shid Moosavi; Saeed C Ashtiyani; Saman Hosseinkhani; Mehdi Shirazi
Journal:  Urol Res       Date:  2009-11-26

10.  Measurement of urinary biomarkers in a case of tubulointerstitial nephritis and uveitis syndrome during glucocorticoid treatment.

Authors:  Masafumi Sugiyama
Journal:  CEN Case Rep       Date:  2018-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.